Cargando…
The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis
BACKGROUND: Coronavirus disease 2019 (COVID-19) is a new acute espiratory infectious disease that has been in a public health emergency of international concern. In China, the combination of Xuanfei Baidu Formula (XBF) and conventional drug is used in the clinical treatment of patients with new coro...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837860/ https://www.ncbi.nlm.nih.gov/pubmed/33546023 http://dx.doi.org/10.1097/MD.0000000000024129 |
_version_ | 1783643040109297664 |
---|---|
author | Li, Fan Li, Yajuan Zhang, Jingxia Li, Shasha Mao, Ajuan Zhao, Chongbo Wang, Weifeng Li, Fang |
author_facet | Li, Fan Li, Yajuan Zhang, Jingxia Li, Shasha Mao, Ajuan Zhao, Chongbo Wang, Weifeng Li, Fang |
author_sort | Li, Fan |
collection | PubMed |
description | BACKGROUND: Coronavirus disease 2019 (COVID-19) is a new acute espiratory infectious disease that has been in a public health emergency of international concern. In China, the combination of Xuanfei Baidu Formula (XBF) and conventional drug is used in the clinical treatment of patients with new coronary pneumonia, However, there is no comprehensive and systematic evidence on the effectiveness and safety of XBF. MATERIALS AND METHODS: We search for research in PubMed, China National Knowledge Infrastructure, Wan-fang Database, China Biomedical Database, and Chinese Science Citation Database. For “Xuanfei Baidu Formula” and “COVID-19,” we screened suitable articles without language restrictions on keywords, Review Manager 5.3 and STATA 14.2 software was used for the data analysis. RESULTS: The systematic review and meta-analysis will evaluate the efficacy and safety of XBF combined with conventional drug in the treatment of COVID-19. CONCLUSION: We will provide evidence of XBF for the treatment on COVID-19 patients. INPLASY REGISTRATION NUMBER: INPLASY2020120011 |
format | Online Article Text |
id | pubmed-7837860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-78378602021-01-27 The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis Li, Fan Li, Yajuan Zhang, Jingxia Li, Shasha Mao, Ajuan Zhao, Chongbo Wang, Weifeng Li, Fang Medicine (Baltimore) 3800 BACKGROUND: Coronavirus disease 2019 (COVID-19) is a new acute espiratory infectious disease that has been in a public health emergency of international concern. In China, the combination of Xuanfei Baidu Formula (XBF) and conventional drug is used in the clinical treatment of patients with new coronary pneumonia, However, there is no comprehensive and systematic evidence on the effectiveness and safety of XBF. MATERIALS AND METHODS: We search for research in PubMed, China National Knowledge Infrastructure, Wan-fang Database, China Biomedical Database, and Chinese Science Citation Database. For “Xuanfei Baidu Formula” and “COVID-19,” we screened suitable articles without language restrictions on keywords, Review Manager 5.3 and STATA 14.2 software was used for the data analysis. RESULTS: The systematic review and meta-analysis will evaluate the efficacy and safety of XBF combined with conventional drug in the treatment of COVID-19. CONCLUSION: We will provide evidence of XBF for the treatment on COVID-19 patients. INPLASY REGISTRATION NUMBER: INPLASY2020120011 Lippincott Williams & Wilkins 2021-01-22 /pmc/articles/PMC7837860/ /pubmed/33546023 http://dx.doi.org/10.1097/MD.0000000000024129 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 3800 Li, Fan Li, Yajuan Zhang, Jingxia Li, Shasha Mao, Ajuan Zhao, Chongbo Wang, Weifeng Li, Fang The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis |
title | The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis |
title_full | The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis |
title_fullStr | The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis |
title_full_unstemmed | The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis |
title_short | The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysis |
title_sort | therapeutic efficacy of xuanfei baidu formula combined with conventional drug in the treatment of coronavirus disease 2019: a protocol for systematic review and meta-analysis |
topic | 3800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837860/ https://www.ncbi.nlm.nih.gov/pubmed/33546023 http://dx.doi.org/10.1097/MD.0000000000024129 |
work_keys_str_mv | AT lifan thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT liyajuan thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT zhangjingxia thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT lishasha thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT maoajuan thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT zhaochongbo thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT wangweifeng thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT lifang thetherapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT lifan therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT liyajuan therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT zhangjingxia therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT lishasha therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT maoajuan therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT zhaochongbo therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT wangweifeng therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis AT lifang therapeuticefficacyofxuanfeibaiduformulacombinedwithconventionaldruginthetreatmentofcoronavirusdisease2019aprotocolforsystematicreviewandmetaanalysis |